AnuBio Selected for Plug and Play Lifetech Accelerator (Batch 2)

2 min read

Selected for Plug and Play Lifetech Accelerator

We’re proud to announce that AnuBio has been selected as one of 12 companies for Batch 2 of the Plug and Play Tech Center Lifetech Accelerator in Indianapolis, chosen from a highly competitive pool of over 800 startups.

About the Program

This accelerator, powered by the IU Launch Accelerator for Biosciences (IU LAB) in partnership with Indiana University and Indiana University Health, is designed to bridge the gap between breakthrough scientific discovery and real-world clinical impact.

A Cohort Driving Innovation

Batch 2 represents a new wave of innovation across precision medicine, advanced diagnostics, oncology, neuroscience, regenerative medicine, and digital health. AnuBio joins a cohort of forward-thinking companies working to overcome critical challenges in commercialization, regulatory strategy, and clinical adoption.

Advancing the Future of Drug Discovery

At AnuBio, our focus has been on addressing one of the most fundamental bottlenecks in drug discovery: the inability to reliably predict multicellular biological responses. While much of the industry has concentrated on identifying better targets or designing better molecules, we believe the real unlock lies in understanding and predicting how complex cellular systems respond to therapeutic intervention.

Looking Ahead

We’re excited to engage with the broader Indianapolis life sciences ecosystem and contribute to a growing hub of translational innovation. This milestone marks an important step forward in our mission to redefine how drugs are discovered and developed.

Connect With Us

If you’re interested in partnering, investing, or collaborating with AnuBio, we’d love to connect.

— Adrian Grzybowski Co-founder, AnuBio